1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 1: 
Clinical and imaging outcomes
GPIIb/IIIa Inhibitors (n = 54)Cangrelor (n = 15)Total (n = 69)P Value
Arterial occlusion lesion score 2–344/54 (81.5%)15/15 (100.0%)59/69 (85.5%).071
Final mTICI 2b-339/54 (75.0%)14/15 (93.3%)53/69 (79.1%).124
Final mTICI 2c-316/52 (30.8%)12/15 (80.0%)28/67 (41.8%)<.001
Final mTICI 311/52 (21.2%)7/15 (46.7%)18/67 (26.9%).050
Puncture-to-recanalization delay (median) (IQR)80 (55−133)107 (82–149)87 (58–135).573
Perioperative complication11/54 (20.4%)1/15 (6.7%)12/69 (17.4%).215
Day 1 NIHSS (median) (IQR)a12 (7–16)11 (5–16)12 (6–16).462
Day 1 ASPECTS (median) (IQR)6 (4–7)7 (6–8)6 (4–7).089
Intracranial artery patency on day 1 imaging follow-up42/54 (79.2%)13/15 (86.7%)55/69 (80.9%).519
Any ICH20/54 (37.0%)4/15 (26.7%)24/69 (34.8%).456
sICH0/53 (0.0%)1/15 (6.7%)1 /68 (1.5%).058
ECASS hemorrhage subtypes.798
    HI-18/53 (15.1%)2/15 (13.3%)10/68 (14.7%)
    HI-27/53 (13.2%)1/15 (6.7%)8/68 (11.8%)
    PH-11/53 (1.9%)1/15 (6.7%)2/68 (2.9%)
    PH-20/53 (0%)0/15 (0%)0/69 (0%)
Remote ICH1/53 (1.9%)0/15 (0.0%)1/68 (1.5%)
Subarachnoid hemorrhage2/53 (3.8%)0/15 (0.0%)2/68 (2.9%)
90-Day mRS 0–217/54 (31.5%)6/15 (40.0%)23/69 (33.3%).536
90-Day mortality16/54 (29.6%)3/15 (20.0%)19/69 (27.5%).460
  • Note:—IQR indicates interquartile range; HI-1, hemorrhagic infarction type 1; HI-2, hemorrhagic infarction type 2; PH-1, parenchymal hematoma type 1; PH-2, parenchymal hematoma type 2.
  • ↵a Missing values in 26 patients.